Publication | Closed Access
Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer.
183
Citations
36
References
2003
Year
Our results indicate that 18F-FDG PET is a useful diagnostic modality for advanced, metastatic, or recurrent gastric cancer but not for detecting bone metastases, peritonitis, or pleuritis carcinomatoses. 18F-FDG uptake by gastric cancers is relatively high but does not parallel histopathologic features of malignancy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1